Related references
Note: Only part of the references are listed.Involvement of ApoE E4 and H63D in Sporadic Alzheimer's Disease in a Folate-Supplemented Ontario Population
Maire Percy et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Drug Development Based on the Metals Hypothesis of Alzheimer's Disease
Ashley I. Bush
JOURNAL OF ALZHEIMERS DISEASE (2017)
Decreased Plasma Iron in Alzheimer's Disease Is Due to Transferrin Desatu ration
Dominic J. Hare et al.
ACS CHEMICAL NEUROSCIENCE (2015)
Decrease in APP and CP mRNA expression supports impairment of iron export in Alzheimer's disease patients
Claudia Guerreiro et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
Parkinson's Disease Iron Deposition Caused by Nitric Oxide-Induced Loss of β-Amyloid Precursor Protein
Scott Ayton et al.
JOURNAL OF NEUROSCIENCE (2015)
High nigral iron deposition in LRRK2 and Parkin mutation carriers using R2*relaxometry
Nadya Pyatigorskaya et al.
MOVEMENT DISORDERS (2015)
Ferroptosis as a p53-mediated activity during tumour suppression
Le Jiang et al.
NATURE (2015)
Is early-life iron exposure critical in neurodegeneration?
Dominic J. Hare et al.
NATURE REVIEWS NEUROLOGY (2015)
R2*mapping for brain iron: associations with cognition in normal aging
Christine Ghadery et al.
NEUROBIOLOGY OF AGING (2015)
Clioquinol rescues Parkinsonism and dementia phenotypes of the tau knockout mouse
Peng Lei et al.
NEUROBIOLOGY OF DISEASE (2015)
Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE
Scott Ayton et al.
NATURE COMMUNICATIONS (2015)
Intranasal deferoxamine attenuates synapse loss via up-regulating the P38/HIF-1α pathway on the brain of APP/PS1 transgenic mice
Chuang Guo et al.
FRONTIERS IN AGING NEUROSCIENCE (2015)
Nitric oxide induces hypoxia ischemic injury in the neonatal brain via the disruption of neuronal iron metabolism
Qing Lu et al.
REDOX BIOLOGY (2015)
Essential versus accessory aspects of cell death: recommendations of the NCCD 2015
L. Galluzzi et al.
CELL DEATH AND DIFFERENTIATION (2015)
A novel model for brain iron uptake: introducing the concept of regulation
Ian A. Simpson et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2015)
Biometals and Their Therapeutic Implications in Alzheimer's Disease
Scott Ayton et al.
NEUROTHERAPEUTICS (2015)
Targeting Chelatable Iron as a Therapeutic Modality in Parkinson's Disease
David Devos et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Brain Iron Homeostasis: From Molecular Mechanisms To Clinical Significance and Therapeutic Opportunities
Neena Singh et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
A comparison of ceruloplasmin to biological polyanions in promoting the oxidation of Fe2+ under physiologically relevant conditions
Bruce X. Wong et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2014)
sAPP modulates iron efflux from brain microvascular endothelial cells by stabilizing the ferrous iron exporter ferroportin
Ryan C. McCarthy et al.
EMBO REPORTS (2014)
The Molecular Biology of Human Iron Metabolism
William E. Winter et al.
LABMEDICINE (2014)
The role of iron in brain ageing and neurodegenerative disorders
Roberta Ward et al.
LANCET NEUROLOGY (2014)
Motor and cognitive deficits in aged tau knockout mice in two background strains
Peng Lei et al.
MOLECULAR NEURODEGENERATION (2014)
Iron accumulation confers neurotoxicity to a vulnerable population of nigral neurons: implications for Parkinson's disease
Scott Ayton et al.
MOLECULAR NEURODEGENERATION (2014)
An anemia of Alzheimer's disease
N. G. Faux et al.
MOLECULAR PSYCHIATRY (2014)
Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice
Jose Pedro Friedmann Angeli et al.
NATURE CELL BIOLOGY (2014)
The role of iron and reactive oxygen species in cell death
Scott J. Dixon et al.
NATURE CHEMICAL BIOLOGY (2014)
H63D mutation in hemochromatosis alters cholesterol metabolism and induces memory impairment
Fatima Ali-Rahmani et al.
NEUROBIOLOGY OF AGING (2014)
Widespread age-related differences in the human brain microstructure revealed by quantitative magnetic resonance imaging
Martina F. Callaghan et al.
NEUROBIOLOGY OF AGING (2014)
Apolipoprotein E: Structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases
Yadong Huang et al.
NEUROBIOLOGY OF DISEASE (2014)
MRI for Iron Mapping in Alzheimer's Disease
Christian Langkammer et al.
NEURODEGENERATIVE DISEASES (2014)
Neuromelanin of the Human Substantia Nigra: An Update
Fabio A. Zucca et al.
NEUROTOXICITY RESEARCH (2014)
β-Amyloid Precursor Protein Does Not Possess Ferroxidase Activity but Does Stabilize the Cell Surface Ferrous Iron Exporter Ferroportin
Bruce X. Wong et al.
PLOS ONE (2014)
An iron-dopamine index predicts risk of parkinsonian neurodegeneration in the substantia nigra pars compacta
Dominic J. Hare et al.
CHEMICAL SCIENCE (2014)
The physiological functions of on regulatory proteins in iron homeostasis - an update
De-Liang Zhang et al.
FRONTIERS IN PHARMACOLOGY (2014)
Labile iron in cells and body fluids: physiology, pathology, and pharmacology
Zvi Ioav Cabantchik
FRONTIERS IN PHARMACOLOGY (2014)
Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease
Scott Ayton et al.
ANNALS OF NEUROLOGY (2013)
Isogenic Human iPSC Parkinson's Model Shows Nitrosative Stress-Induced Dysfunction in MEF2-PGC1α Transcription
Scott D. Ryan et al.
CELL (2013)
Deletion of Iron Regulatory Protein 1 Causes Polycythemia and Pulmonary Hypertension in Mice through Translational Derepression of HIF2α
Manik C. Ghosh et al.
CELL METABOLISM (2013)
Chronic intranasal deferoxamine ameliorates motor defects and pathology in the α-synuclein rAAV Parkinson's model
Fabia Febbraro et al.
EXPERIMENTAL NEUROLOGY (2013)
Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators
Orly Weinreb et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Perinatal iron deficiency and neurocognitive development
Emily C. Radlowski et al.
FRONTIERS IN HUMAN NEUROSCIENCE (2013)
Ferroportin and Exocytoplasmic Ferroxidase Activity Are Required for Brain Microvascular Endothelial Cell Iron Efflux
Ryan C. McCarthy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Excess iron harms the brain: the syndromes of neurodegeneration with brain iron accumulation (NBIA)
Susanne A. Schneider et al.
JOURNAL OF NEURAL TRANSMISSION (2013)
Roles of the amyloid precursor protein family in the peripheral nervous system
John H. Caldwell et al.
MECHANISMS OF DEVELOPMENT (2013)
Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease
Chuang Guo et al.
NEUROBIOLOGY OF AGING (2013)
Metal dyshomeostasis and oxidative stress in Alzheimer's disease
Mark A. Greenough et al.
NEUROCHEMISTRY INTERNATIONAL (2013)
Profiling the iron, copper and zinc content in primary neuron and astrocyte cultures by rapid online quantitative size exclusion chromatography-inductively coupled plasma-mass spectrometry
Dominic J. Hare et al.
METALLOMICS (2013)
The Correlation of Hippocampal T2-Mapping with Neuropsychology Test in Patients with Alzheimer's Disease
Zhuren Luo et al.
PLOS ONE (2013)
Iron Accumulates in Huntington's Disease Neurons: Protection by Deferoxamine
Jianfang Chen et al.
PLOS ONE (2013)
A delicate balance: Iron metabolism and diseases of the brain
Dominic Hare et al.
FRONTIERS IN AGING NEUROSCIENCE (2013)
Serum Iron Levels and the Risk of Parkinson Disease: A Mendelian Randomization Study
Irene Pichler et al.
PLOS MEDICINE (2013)
Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease
Gael Chetelat et al.
NEUROIMAGE-CLINICAL (2013)
Non-transferrin bound iron in Thalassemia: Differential detection of redox active forms in children and older patients
William Breuer et al.
AMERICAN JOURNAL OF HEMATOLOGY (2012)
Alzheimer's Disease: Redox Dysregulation As a Common Denominator for Diverse Pathogenic Mechanisms
Rommy von Bernhardi et al.
ANTIOXIDANTS & REDOX SIGNALING (2012)
Non-transferrin bound iron: A key role in iron overload and iron toxicity
Pierre Brissot et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2012)
Mammalian iron metabolism and its control by iron regulatory proteins
Cole P. Anderson et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2012)
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Scott J. Dixon et al.
CELL (2012)
Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export
Peng Lei et al.
NATURE MEDICINE (2012)
Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons
M. Decressac et al.
NEUROBIOLOGY OF DISEASE (2012)
MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping
Berkin Bilgic et al.
NEUROIMAGE (2012)
Long-term improvement under deferiprone in a case of neurodegeneration with brain iron accumulation
A. Kwiatkowski et al.
PARKINSONISM & RELATED DISORDERS (2012)
Systemic and cellular consequences of macrophage control of iron metabolism
S. Recalcati et al.
SEMINARS IN IMMUNOLOGY (2012)
Intranasal deferoxamine improves performance in radial arm water maze, stabilizes HIF-1α, and phosphorylates GSK3β in P301L tau transgenic mice
J. M. Fine et al.
EXPERIMENTAL BRAIN RESEARCH (2012)
Regulation of cellular iron metabolism
Jian Wang et al.
BIOCHEMICAL JOURNAL (2011)
Iron loading-induced aggregation and reduction of iron incorporation in heteropolymeric ferritin containing a mutant light chain that
Barry B. Muhoberac et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Childhood disorders of neurodegeneration with brain iron accumulation (NBIA)
Manju A. Kurian et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2011)
H-ferritin is the Major Source of Iron for Oligodendrocytes
Bozho Todorich et al.
GLIA (2011)
Iron Promotes the Toxicity of Amyloid β Peptide by Impeding Its Ordered Aggregation
Beinan Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Investigation on positive correlation of increased brain iron deposition with cognitive impairment in Alzheimer disease by using quantitative MR R2' mapping
Yuanyuan Qin et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2011)
The Alzheimer's therapeutic PBT2 promotes amyloid-β degradation and GSK3 phosphorylation via a metal chaperone activity
Peter J. Crouch et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Ceruloplasmin Oxidation, a Feature of Parkinson's Disease CSF, Inhibits Ferroxidase Activity and Promotes Cellular Iron Retention
Stefano Olivieri et al.
JOURNAL OF NEUROSCIENCE (2011)
HFE Gene Variants Affect Iron in the Brain
Wint Nandar et al.
JOURNAL OF NUTRITION (2011)
Differential effects of age and history of hypertension on regional brain volumes and iron
Karen M. Rodrigue et al.
NEUROIMAGE (2011)
Metal Ionophore Treatment Restores Dendritic Spine Density and Synaptic Protein Levels in a Mouse Model of Alzheimer's Disease
Paul A. Adlard et al.
PLOS ONE (2011)
Hepcidin and Ferroportin: The New Players in Iron Metabolism
Ivana De Domenico et al.
SEMINARS IN LIVER DISEASE (2011)
Iron Homeostasis and the Inflammatory Response
Marianne Wessling-Resnick
ANNUAL REVIEW OF NUTRITION, VOL 30 (2010)
Cytosolic and mitochondrial ferritins in the regulation of cellular iron homeostasis and oxidative damage
Paolo Arosio et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2010)
Iron-Export Ferroxidase Activity of β-Amyloid Precursor Protein Is Inhibited by Zinc in Alzheimer's Disease
James A. Duce et al.
CELL (2010)
Genetic Etiology of Parkinson Disease Associated with Mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 Genes: A Mutation Update
Karen Nuytemans et al.
HUMAN MUTATION (2010)
Tau protein: Relevance to Parkinson's disease
Peng Lei et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2010)
Increased Iron and Free Radical Generation in Preclinical Alzheimer Disease and Mild Cognitive Impairment
Mark A. Smith et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Iron and Other Metals in Neuromelanin, Substantia Nigra, and Putamen of Human Brain
Luigi Zecca et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Metals, oxidative stress and neurodegenerative disorders
Klaudia Jomova et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2010)
Binding and uptake of H-ferritin are mediated by human transferrin receptor-1
Li Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Iron, the substantia nigra and related neurological disorders
Amanda M. Snyder et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2009)
Ferritins: A family of molecules for iron storage, antioxidation and more
Paolo Arosio et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2009)
Iron absorption and metabolism
Gregory J. Anderson et al.
CURRENT OPINION IN GASTROENTEROLOGY (2009)
Clioquinol Decreases Amyloid-beta Burden and Reduces Working Memory Impairment in a Transgenic Mouse Model of Alzheimer's Disease
Cristina Grossi et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Correlation of Iron in the Hippocampus with MMSE in Patients with Alzheimer's Disease
Bei Ding et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2009)
Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer disease
Joseph L. Price et al.
NEUROBIOLOGY OF AGING (2009)
MRI estimates of brain iron concentration in normal aging: Comparison of field-dependent (FDRI) and phase (SWI) methods
Adolf Pfefferbaum et al.
NEUROIMAGE (2009)
Brain iron homeostasis, the choroid plexus, and localization of iron transport proteins
Tracey A. Rouault et al.
METABOLIC BRAIN DISEASE (2009)
Quantitative MR Phase-corrected Imaging to Investigate Increased Brain Iron Deposition of Patients with Alzheimer Disease
Wen-zhen Zhu et al.
RADIOLOGY (2009)
Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005
Erin McLean et al.
PUBLIC HEALTH NUTRITION (2009)
Systemic Iron Homeostasis and the Iron-Responsive Element/Iron-Regulatory Protein (IRE/IRP) Regulatory Network
Martina U. Muckenthaler et al.
Annual Review of Nutrition (2008)
Furin-mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis
Laura Silvestri et al.
BLOOD (2008)
Targeting multiple Alzheimer's disease etiologies with multimodal neuroprotective and neurorestorative iron chelators
Tamar Amit et al.
FASEB JOURNAL (2008)
Intracellular labile iron
William Breuer et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
A potential pathogenetic role of iron in Alzheimer's disease
Laura Silvestri et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Tim-2 is the receptor for H-ferritin on oligodendrocytes
Bozho Todorich et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Aβ
Paul A. Adlard et al.
NEURON (2008)
Chemistry and Antihypertensive Effects of Tempol and Other Nitroxides
C. S. Wilcox et al.
PHARMACOLOGICAL REVIEWS (2008)
Tempol-mediated activation of latent iron regulatory protein activity prevents symptoms of neurodegenerative disease in IRP2 knockout mice
Manik C. Ghosh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease
Julio Salazar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Twenty years of metallo-neurobiology: where to now?
Ashley I. Bush et al.
EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS (2008)
Iron trafficking inside the brain
Torben Moos et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Myelin breakdown and iron changes in Huntington's disease: Pathogenesis and treatment implications
George Bartzokis et al.
NEUROCHEMICAL RESEARCH (2007)
Selective iron chelation in Friedreich ataxia:: biologic and clinical implications
Nathalie Boddaert et al.
BLOOD (2007)
Brain structural alterations before mild cognitive impairment
C. D. Smith et al.
NEUROLOGY (2007)
Cellular iron status influences the functional relationship between microglia and Oligodendrocytes
X. Zhang et al.
GLIA (2006)
Two-year follow-up of amyloid deposition in patients with Alzheimer's disease
Henry Engler et al.
BRAIN (2006)
Brain capillary endothelial cells mediate iron transport into the brain by segregating iron from transferrin without the involvement of divalent metal transporter 1
Torben Moos et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Characterization of the L-ferritin variant 460InsA responsible of a hereditary ferritinopathy disorder
Anna Cozzi et al.
NEUROBIOLOGY OF DISEASE (2006)
Association of HFE common mutations with Parkinson's disease, Alzheimer's disease and mild cognitive impairment in a Portuguese cohort
Rita J. Guerreiro et al.
BMC NEUROLOGY (2006)
p53-mediated apoptosis, neuroglobin overexpression, and globin deposits in a patient with hereditary ferritinopathy
James M. Powers
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus
Qin Xu et al.
JOURNAL OF NEUROSCIENCE (2006)
Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment
HM Schipper et al.
NEUROBIOLOGY OF AGING (2006)
DNA and mRNA elements with complementary responses to hemin, antioxidant inducers, and iron control ferritin-L expression
KJ Hintze et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Hemochromatosis and iron-overload screening in a racially diverse population
PC Adams et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Hereditary ferritinopathy: A novel mutation, its cellular pathology, and pathogenetic insights
M Mancuso et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2005)
The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis
A Donovan et al.
CELL METABOLISM (2005)
Imaging iron stores in the brain using magnetic resonance imaging
EM Haacke et al.
MAGNETIC RESONANCE IMAGING (2005)
Brain iron uptake in hypotransferrinemic mice: Influence of systemic iron status
JL Beard et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2005)
Expression of the iron transporter ferroportin in synaptic vesicles and the blood-brain barrier
LJC Wu et al.
BRAIN RESEARCH (2004)
Neurodegenerative diseases and oxidative stress
KJ Barnham et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Brain capillary endothelium and choroid plexus epithelium regulate transport of transferrin-bound and free iron into the rat brain
R Deane et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis
EG Meyron-Holtz et al.
EMBO JOURNAL (2004)
Effect of manipulation of iron storage, transport, or availability on myelin composition and brain iron content in three different animal models
E Ortiz et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2004)
Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's Aβ peptides
XD Huang et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2004)
The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging
L Zecca et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Iron, brain ageing and neurodegenerative disorders
L Zecca et al.
NATURE REVIEWS NEUROSCIENCE (2004)
The significance of the mutated divalent metal transporter (DMT1) on iron transport into the Belgrade rat brain
T Moos et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Hereditary early-onset Parkinson's disease caused by mutations in PINK1
EM Valente et al.
SCIENCE (2004)
The TIM gene family:: Emerging roles in immunity and disease
VK Kuchroo et al.
NATURE REVIEWS IMMUNOLOGY (2003)
Association of HFE mutations with neurodegeneration and oxidative stress in Alzheimer's disease and correlation with APOE
JF Pulliam et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2003)
The metallobiology of Alzheimer's disease
AI Bush
TRENDS IN NEUROSCIENCES (2003)
Association between the HFE mutations and unsuccessful ageing: a study in Alzheimer's disease patients from Northern Italy
G Candore et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2003)
Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: A novel therapy for Parkinson's disease
D Kaur et al.
NEURON (2003)
Nrf2 mediates the induction of ferritin H in response to xenobiotics and cancer chemopreventive dithiolethiones
EC Pietsch et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism
V Bonifati et al.
SCIENCE (2003)
Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting A beta amyloid deposition and toxicity in Alzheimer disease - A pilot phase 2 clinical trial
CW Ritchie et al.
ARCHIVES OF NEUROLOGY (2003)
Interaction of the H63D mutation in the hemochromatosis gene with the apolipoprotein E epsilon 4 allele modulates age at onset of Alzheimer's disease
O Combarros et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2003)
Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases?
G Perry et al.
FREE RADICAL BIOLOGY AND MEDICINE (2002)
Pathogenesis of Parkinson's disease:: Dopamine, vesicles and α-synuclein
J Lotharius et al.
NATURE REVIEWS NEUROSCIENCE (2002)
An iron-responsive element type II in the 5′-untranslated region of the Alzheimer's amyloid precursor protein transcript
JT Rogers et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson's disease
BA Faucheux et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Metal-triggered structural transformations, aggregation, and fibrillation of human α-synuclein -: A possible molecular link between Parkinson's disease and heavy metal exposure
VN Uversky et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The hemochromatosis gene affects the age of onset of sporadic Alzheimer's disease
M Sampietro et al.
NEUROBIOLOGY OF AGING (2001)
Treatment with a copper-zinc chelator markedly and rapidly inhibits β-amyloid accumulation in Alzheimer's disease transgenic mice
RA Cherny et al.
NEURON (2001)
Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages:: consequences for iron storage and neurodegenerative processes
L Zecca et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Heme oxygenase-1 (HSP-32) and heme oxygenase-2 induction in neurons and glial cells of cerebral regions and its relation to iron accumulation after focal cortical photothrombosis
HJ Bidmon et al.
EXPERIMENTAL NEUROLOGY (2001)
Desferrioxamine-chelatable iron, a component of serum non-transferrin-bound iron, used for assessing chelation therapy
W Breuer et al.
BLOOD (2001)
Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice
T LaVaute et al.
NATURE GENETICS (2001)
The importance of non-transferrin bound iron in disorders of iron metabolism
W Breuer et al.
TRANSFUSION SCIENCE (2000)
Sequestration of iron by Lewy bodies in Parkinson's disease
RJ Castellani et al.
ACTA NEUROPATHOLOGICA (2000)
Share Paper
